Conners Clinic

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

The claims on your website and social media websites establish that the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease.

Passage 2

Your “Fenbendazole Starter Pack #1”, “Panacur-C Fenbendazole”, “Breast Cancer Prevention Protocol Bundle”, “Curcu Clear”, “Black Cumin Seed Oil”, “Chronic LX”, “Cayenne”, “D3- Xym”, “Rapid Immune Boost,” and “Glucosamine Sulfate Chondroitin Sulfate MSM” products are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are “new drugs” under section 201(p) of the Act [21 U.S.C. § 321(p)].